{
  "drug_name": "Baloxavir_marboxil",
  "url": "https://wikem.org/wiki/Baloxavir_marboxil",
  "scraped_at": "2026-01-10T07:48:34.443601",
  "sections": {
    "Administration": {
      "text": "Type:\nAntiviral\nDosage Forms: 20 mg, 40 mg tab\nRoutes of Administration: PO\nCommon Trade Names: Xofluza",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antiviral",
          "url": "https://wikem.org/wiki/Antiviral"
        }
      ]
    },
    "Indications": {
      "text": "Influenza",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Influenza",
          "url": "https://wikem.org/wiki/Influenza"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "40-79.9 kg: 40 mg PO x1\nStart within 48 hours of symptom onset\nAvoid co-administration with dairy products, calcium supplements\n>80 mg: 80 mg PO x1\nStart within 48 hours of symptom onset\nAvoid co-administration with dairy products, calcium supplements",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Approved for use in pediatric patients 12 and older\n40-79.9 kg: 40 mg PO x1\nStart within 48 hours of symptom onset\nAvoid co-administration with dairy products, calcium supplements\n>80 mg: 80 mg PO x1\nStart within 48 hours of symptom onset\nAvoid co-administration with dairy products, calcium supplements",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Category\n: Not assigned (insufficient data)\nLactation risk\n: Avoid use while breastfeeding",
      "subsections": {
        "Renal_Dosing": {
          "text": "Adult and Pediatric:\nCrCl>50: no adjustment\nCrCl<50 or HD/PD: not defined",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Adult and Pediatric:\nChild-Pugh Class A or B: no adjustment\nChild-Pugh Class C: not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Category",
          "url": "https://wikem.org/wiki/Pregnancy_Category"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk"
        }
      ]
    },
    "Renal_Dosing": {
      "text": "Adult and Pediatric:\nCrCl>50: no adjustment\nCrCl<50 or HD/PD: not defined",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "Adult and Pediatric:\nChild-Pugh Class A or B: no adjustment\nChild-Pugh Class C: not defined",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "Adult and Pediatric:\nChild-Pugh Class A or B: no adjustment\nChild-Pugh Class C: not defined",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nPregnancy\nBreastfeeding",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Anaphylaxis\nAngioedema\nErythema multiforme\nUrticaria",
          "tables": []
        },
        "Common": {
          "text": "Nausea (Especially in older patients)",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Angioedema",
          "url": "https://wikem.org/wiki/Angioedema"
        },
        {
          "text": "Erythema multiforme",
          "url": "https://wikem.org/wiki/Erythema_multiforme"
        },
        {
          "text": "Urticaria",
          "url": "https://wikem.org/wiki/Urticaria"
        }
      ]
    },
    "Serious": {
      "text": "Anaphylaxis\nAngioedema\nErythema multiforme\nUrticaria",
      "subsections": {
        "Common": {
          "text": "Nausea (Especially in older patients)",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Angioedema",
          "url": "https://wikem.org/wiki/Angioedema"
        },
        {
          "text": "Erythema multiforme",
          "url": "https://wikem.org/wiki/Erythema_multiforme"
        },
        {
          "text": "Urticaria",
          "url": "https://wikem.org/wiki/Urticaria"
        }
      ]
    },
    "Common": {
      "text": "Nausea (Especially in older patients)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 79.1 hours\nMetabolism: liver (CYP450)\nExcretion: Feces (predominant), urine\n[1]",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Inhibits viral polymerase acidic protein endonuclease activity, which inhibits viral replications",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Comments": {
      "text": "Only approved for patients >12 years old and >40kg in weight, no current safety data exists for pregnancy and breastfeeding.\n[2]\nMore expensive but one time dosing. Genentech, its creator, states a recent phase III trial has shown it to be effective for prophylaxis but not currently FDA indicated for this.\n[3]",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Influenza\nAntiviral\nTamiflu\n/\nOseltamivir",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Influenza",
          "url": "https://wikem.org/wiki/Influenza"
        },
        {
          "text": "Antiviral",
          "url": "https://wikem.org/wiki/Antiviral"
        },
        {
          "text": "Tamiflu",
          "url": "https://wikem.org/wiki/Tamiflu"
        },
        {
          "text": "Oseltamivir",
          "url": "https://wikem.org/wiki/Oseltamivir"
        }
      ]
    }
  }
}